Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

BK-alpha activates KCNMA1. 3 / 3

| 3

➶

reach

"Third, pharmacologic activation of Nrf2 by FDA approved Nrf2 activators promoted Nrf2 nuclear translocation, augmented BK-alpha and BK-beta1 expression, and enhanced BK channel activity in vascular SMCs."

32147517

➶

reach

"Treatment with FDA approved Nrf2 activators augmented BK-alpha and BK-beta1 expression and enhanced BK channel activity in arterial SMCs."

32147517

➶

reach

"Adenoviral expression and pharmacological activation of Nrf2 increased BK-alpha and BK-beta1 protein levels and enhanced BK channel activity in coronary arterial SMCs."

32147517

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

BK-alpha activates KCNMA1. 3 / 3

Our Sources:

Databases

Reading